Results 201 to 210 of about 2,701,466 (355)
Spatial Proximity of LAG-3 and T Cell Receptor: A New Paradigm for T Cell Suppression. [PDF]
Miao X, Feng X, Zhou F.
europepmc +1 more source
Clonal rearrangements of T-cell receptor and immunoglobul in genes as sensitive marker for bone marrow involvement in non-Hodgkin's lymphoma [PDF]
Martin Krönke +4 more
openalex +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
The resting and ligand-bound states of the membrane-embedded human T-cell receptor-CD3 complex. [PDF]
Notti RQ +8 more
europepmc +1 more source
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed +10 more
wiley +1 more source
ALIGaToR: a tool for the automated annotation of immunoglobulin and T cell receptor genomic loci. [PDF]
Schramm CA, Olubo S, Douek DC.
europepmc +1 more source
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source
TRAIT: A Comprehensive Database for T-cell Receptor-antigen Interactions. [PDF]
Wei M +11 more
europepmc +1 more source

